Poplar Therapeutics News and Activities

Acquisition, funding and merger involving Poplar Therapeutics.

• Poplar Therapeutics has just announced a $45 Million fundraising (posted on March 4 2026).
• Poplar Therapeutics has just announced a $50 Million fundraising (posted on January 9 2026).

View the org chart displaying its 3 main executives

Most searched biographies at Poplar Therapeutics

• Chip Baird, Chief Executive Officer
• Kelley Dolliver, Senior Manager of Administrative Business Partner
• Richard Koo, Senior Vice President of Program Management

Create your alert
to follow the executive moves at Poplar Therapeutics.

Poplar Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Poplar Therapeutics

Social media about Poplar Therapeutics

• Poplar Therapeutics on Wikipedia, Google News & Yahoo Finance
• Poplar Therapeutics on LinkedIn, X (Twitter) & YouTube